Adapting to Progress: Axitinib Intravitreal Implant for Wet AMD cover art

Adapting to Progress: Axitinib Intravitreal Implant for Wet AMD

Adapting to Progress: Axitinib Intravitreal Implant for Wet AMD

Listen for free

View show details

About this listen

 David Eichenbaum, MD, will discuss the bioresorbable, hydrogel axitinib intravitreal implant that is under investigation in the SOL-1 phase 3 trial for the treatment of neovascular age-related macular degeneration. This activity is supported by an independent medical education grant from Ocular Therapeutix. Click here to view the webinar event, which includes images from the talk. Want to register with Evolve Medical Education? Click here.
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.